Lonza to Build Cell Therapy Production Facility in Singapore

Lonza says it will build a cell therapy facility in Singapore to expand its global presence and meet growing worldwide demand. Lonza will invest SF30 million ($27 million) in the first construction phase of the plant, which will be located adjacent to Lonza’s large-scale mammalian cell culture facility at Tuas Biomedical Park. Construction is expected to begin in early 2010, with start up of two suites by mid-2011. Borgas: Cell therapy to become important innovation driver. The facility will be designed to accommodate additional suites to meet...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers